Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program save search
Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
MTNB | $0.2025 -0.34% 0.0% 690K
|
Health Technology
|
| O: 74.26%
H: 229.51%
C: 137.32%
mat2203 infection program
Asset Entities Announces Stock Repurchase Program
Published: 2023-11-27 (Crawled : 13:00) - globenewswire.com
ASST | $0.419 4.18% 2.19% 56K
|
|
| O: 12.02%
H: 174.27%
C: 77.76%
repurchase program
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2
Published: 2021-01-19 (Crawled : 11:01) - globenewswire.com
GRTS | $0.7389 -12.15% -14.09% 5.4M
|
Health Technology
|
| O: 38.34%
H: 154.19%
C: 151.92%
covid vaccine potential sars-cov-2 program
Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
Published: 2022-09-06 (Crawled : 12:20) - globenewswire.com
SPRO | $1.53 -6.71% -6.49% 260K
|
Health Technology
|
| O: 14.94%
H: 127.46%
C: 35.28%
drug meeting program therapeutics food update
Singing Machine Announces Termination of its At-the-Market Equity Program
Published: 2023-05-16 (Crawled : 11:00) - globenewswire.com
MICS | $0.8509 0.69% -2.34% 4.8K
|
Manufacturing
|
| O: 20.95%
H: 96.85%
C: 17.32%
program
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
MNPR | $0.755 -3.33% -3.86% 100K
|
Health Technology
|
| O: 36.88%
H: 75.6%
C: 43.55%
mnpr-101 preclinical program advanced
Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship
Published: 2023-08-07 (Crawled : 20:00) - prnewswire.com
CRDF | $5.28 -5.88% -6.55% 580K
|
Health Services
|
| O: 6.37%
H: 67.07%
C: 30.54%
cancer program
Sypris Wins Contract for Deep Space Program
Published: 2021-04-22 (Crawled : 21:00) - ir.sypris.com
SYPR 4 | $1.66 -1.78% -3.68% 77K
|
Producer Manufacturing
|
| O: 28.83%
H: 60.77%
C: 23.48%
space contract spac program
OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program
Published: 2023-05-16 (Crawled : 15:20) - biospace.com/
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 3.9%
H: 54.12%
C: -35.35%
fda melanoma meeting program
XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical TrialBridging Pharmacokinetics Study Part 1 Recruitment Completed for XRx-008 Program for Autosomal Dominant Polycystic Kidney Disease
Published: 2022-05-03 (Crawled : 12:20) - biospace.com/
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 28.45%
H: 53.69%
C: 22.82%
oxy-101 disease kidney program
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
Published: 2023-09-13 (Crawled : 12:00) - globenewswire.com
NMRD | $0.0745 -12.35% -28.78% 16K
|
Health Technology
|
| O: 11.43%
H: 51.28%
C: 15.59%
metabolic service health collaboration medical program results
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
Published: 2022-11-16 (Crawled : 12:00) - globenewswire.com
INM 4 | $0.3187 -3.28% -5.44% 100K
|
Health Technology
|
| O: 12.95%
H: 51.27%
C: 20.7%
pharmaceuticals sciences research disease grant canada program funding neurodegenerative
IGEN and Prolog announce Industry's First AI Program for the Next Generation of Commercial Fleet Solutions
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
IGEN | $0.0002 -50.0% 2.1M
|
Manufacturing
|
| O: 0.0%
H: 50.0%
C: 16.67%
fleet solutions commercial program
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
Published: 2024-03-22 (Crawled : 13:00) - globenewswire.com
MTNB | $0.2025 -0.34% 0.0% 690K
|
Health Technology
|
| O: 8.94%
H: 48.28%
C: -4.14%
mat2203 infection program response
Harbor Custom Development, Inc. Authorizes New Stock Repurchase Program
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
HCDI | $0.199 -24.47% 1.2M
|
Finance
|
| O: 12.5%
H: 46.38%
C: 6.76%
program
Sezzle Board of Directors Authorizes US$5 Million Stock Repurchase Program
Published: 2023-12-22 (Crawled : 14:30) - globenewswire.com
SEZL 4 | $65.21 0.09% -0.94% 24K
|
Finance and Insurance
|
| O: 7.73%
H: 46.01%
C: 29.7%
million repurchase program
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published: 2023-11-22 (Crawled : 12:00) - globenewswire.com
AGNPF | $0.0682 12.17% 178.69% 300
|
Health Technology
|
| O: 7.95%
H: 45.61%
C: 24.56%
acquisition pharmaceuticals research program
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
Published: 2023-10-10 (Crawled : 12:30) - inovio.com
INO | $10.99 -0.36% -0.27% 250K
|
Health Technology
|
| O: 13.73%
H: 45.31%
C: 23.98%
ino-3107 fda approval program trial
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
CMND | $1.255 1.21% -0.81% 25K
|
n/a
|
| O: 8.67%
H: 45.26%
C: 1.53%
SPRC | $1.49 -6.29% -4.95% 410K
|
Manufacturing
|
| O: -2.72%
H: 4.29%
C: -6.69%
metabolic positive treatment program results
Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
CMND | $1.255 1.21% -0.81% 25K
|
n/a
|
| O: 8.67%
H: 45.26%
C: 1.53%
metabolic positive treatment program results
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.